E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research

Online Publishing Date:
11 / 06 / 2024

 


A retrospective cohort study on the potential link between dolutegravir-based anti-retroviral therapy and weight gain compared to efavirenz-based anti-retroviral therapy in a tertiary care center in Jabalpur, Madhya Pradesh

Amal C Anil, Sanjay Gedam, Gargi Sethi, Namita Parashar, Namita Barmaiya, Aryasree L, Shivank Sethi.


Abstract
Background: Anti-retroviral therapies (ARTs) for human immunodeficiency virus (HIV) such as dolutegravir (DTG) and efavirenz have been associated with weight gain. Comparing the weight trajectories of the tenofovir/lamivudine/dolutegravir (TLD) and tenofovir/lamivudine/efavirenz (TLE) regimens can give insights into their differential metabolic impact.

Aims and Objectives: The aim of the study was to analyze and compare weight changes in HIV patients on TLE versus TLD regimens over 6 months at a tertiary health center in Jabalpur.

Materials and Methods: This was a retrospective cohort study of 200 HIV patients (100 each on TLE and TLD regimens) from January 2018 to December 2022. Weight change over three prescription time points was recorded. Patients included if >20 years old, on ART >4 weeks, and adherent. Patients excluded if pregnant, comorbidities present, or on ART <4 weeks.

Results: The mean weight increased from 53.86 kg to 54.83 kg (0.97 kg gain) in the TLE group versus 53.79 kg to 58.34 kg (4.55 kg gain) in the TLD group over 6 months. About 53% of TLD patients had a >5% weight gain versus 33% of TLE patients. Analysis of variance showed no significant difference in TLE weight over time (P = 0.864) but a significant TLD weight gain (P = 0.034).

Conclusion: HIV patients on DTG-containing TLD regimen demonstrated a substantial weight gain, whereas TLE regimen patients saw insignificant change. Over half of the TLD patients experienced a concerning >5% weight increase indicating an unfavorable metabolic impact. Health-care providers need awareness of weight gain linked to these HIV drugs to optimize treatment regimens.

Key words: Human Immunodeficiency Virus, Anti-retroviral Therapy, Dolutegravir, Efavirenz, Tenofovir/Lamivudine/Dolutegravir, Tenofovir/Lamivudine/Efavirenz, Weight Gain


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Amal C Anil
Articles by Sanjay Gedam
Articles by Gargi Sethi
Articles by Namita Parashar
Articles by Namita Barmaiya
Articles by Aryasree L
Articles by Shivank Sethi
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Anil AC, Gedam S, Sethi G, Parashar N, Barmaiya N, L A, Sethi S. A retrospective cohort study on the potential link between dolutegravir-based anti-retroviral therapy and weight gain compared to efavirenz-based anti-retroviral therapy in a tertiary care center in Jabalpur, Madhya Pradesh. Natl J Physiol Pharm Pharmacol. Online First: 11 Jun, 2024. doi:10.5455/njppp.2024.14.05215202429052024


Web Style

Anil AC, Gedam S, Sethi G, Parashar N, Barmaiya N, L A, Sethi S. A retrospective cohort study on the potential link between dolutegravir-based anti-retroviral therapy and weight gain compared to efavirenz-based anti-retroviral therapy in a tertiary care center in Jabalpur, Madhya Pradesh. https://www.njppp.com/?mno=201702 [Access: June 11, 2024]. doi:10.5455/njppp.2024.14.05215202429052024


AMA (American Medical Association) Style

Anil AC, Gedam S, Sethi G, Parashar N, Barmaiya N, L A, Sethi S. A retrospective cohort study on the potential link between dolutegravir-based anti-retroviral therapy and weight gain compared to efavirenz-based anti-retroviral therapy in a tertiary care center in Jabalpur, Madhya Pradesh. Natl J Physiol Pharm Pharmacol. Online First: 11 Jun, 2024. doi:10.5455/njppp.2024.14.05215202429052024



Vancouver/ICMJE Style

Anil AC, Gedam S, Sethi G, Parashar N, Barmaiya N, L A, Sethi S. A retrospective cohort study on the potential link between dolutegravir-based anti-retroviral therapy and weight gain compared to efavirenz-based anti-retroviral therapy in a tertiary care center in Jabalpur, Madhya Pradesh. Natl J Physiol Pharm Pharmacol, [cited June 11, 2024]; Online First: 11 Jun, 2024. doi:10.5455/njppp.2024.14.05215202429052024



Harvard Style

Anil, A. C., Gedam, . S., Sethi, . G., Parashar, . N., Barmaiya, . N., L, . A. & Sethi, . S. (2024) A retrospective cohort study on the potential link between dolutegravir-based anti-retroviral therapy and weight gain compared to efavirenz-based anti-retroviral therapy in a tertiary care center in Jabalpur, Madhya Pradesh. Natl J Physiol Pharm Pharmacol, Online First: 11 Jun, 2024. doi:10.5455/njppp.2024.14.05215202429052024



Turabian Style

Anil, Amal C, Sanjay Gedam, Gargi Sethi, Namita Parashar, Namita Barmaiya, Aryasree L, and Shivank Sethi. 2024. A retrospective cohort study on the potential link between dolutegravir-based anti-retroviral therapy and weight gain compared to efavirenz-based anti-retroviral therapy in a tertiary care center in Jabalpur, Madhya Pradesh. National Journal of Physiology, Pharmacy and Pharmacology, Online First: 11 Jun, 2024. doi:10.5455/njppp.2024.14.05215202429052024



Chicago Style

Anil, Amal C, Sanjay Gedam, Gargi Sethi, Namita Parashar, Namita Barmaiya, Aryasree L, and Shivank Sethi. "A retrospective cohort study on the potential link between dolutegravir-based anti-retroviral therapy and weight gain compared to efavirenz-based anti-retroviral therapy in a tertiary care center in Jabalpur, Madhya Pradesh." National Journal of Physiology, Pharmacy and Pharmacology Online First: 11 Jun, 2024. doi:10.5455/njppp.2024.14.05215202429052024



MLA (The Modern Language Association) Style

Anil, Amal C, Sanjay Gedam, Gargi Sethi, Namita Parashar, Namita Barmaiya, Aryasree L, and Shivank Sethi. "A retrospective cohort study on the potential link between dolutegravir-based anti-retroviral therapy and weight gain compared to efavirenz-based anti-retroviral therapy in a tertiary care center in Jabalpur, Madhya Pradesh." National Journal of Physiology, Pharmacy and Pharmacology Online First: 11 Jun, 2024. Web. 11 Jun 2024 doi:10.5455/njppp.2024.14.05215202429052024



APA (American Psychological Association) Style

Anil, A. C., Gedam, . S., Sethi, . G., Parashar, . N., Barmaiya, . N., L, . A. & Sethi, . S. (2024) A retrospective cohort study on the potential link between dolutegravir-based anti-retroviral therapy and weight gain compared to efavirenz-based anti-retroviral therapy in a tertiary care center in Jabalpur, Madhya Pradesh. National Journal of Physiology, Pharmacy and Pharmacology, Online First: 11 Jun, 2024. doi:10.5455/njppp.2024.14.05215202429052024